Oramed Pharmaceuticals Inc. — Director's Dealing 2016

Sep 8, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2016-08-30

Reporting Person: Friedman Aviad (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9691	Indirect
Common Stock	10000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.36	2016-11-03	Common Stock (3000)		Indirect

Footnotes

F1: One third of the options vest on 1/1/16, one third vest on 4/1/2016 and the remainder vest on 7/1/2016.